Actively Recruiting
Feasibility Study Aiming at Pre-Analytical Standardization of Whole Blood Processing for Liquid Biopsy Applications
Led by Tethis S.p.A. · Updated on 2026-02-12
200
Participants Needed
1
Research Sites
194 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this feasibility study is to evaluate a new sample preparator called See.d. After blood processing the instrument will produce a set of slides and a tube of plasma. These outputs could be used in further analysis in liquid biopsy applications.
CONDITIONS
Official Title
Feasibility Study Aiming at Pre-Analytical Standardization of Whole Blood Processing for Liquid Biopsy Applications
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants are willing and able to give and sign a written informed consent
- Aged 18 or above
You will not qualify if you...
- Ongoing infections requiring antibiotic or antiviral treatment
- Known hemostasis/coagulation disorder
- Known Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ospedale San Raffaele
Milan, Italy, 20132
Actively Recruiting
Research Team
L
Luca Santoleri
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here